Small Molecule SST2 Agonist as a Potential Therapeutic for Acromegaly and Neuroendocrine Tumors

Please copy the URL and add it into your RSS Feed Reader.

Facebook Linkedin Weibo

Synfacts 2023; 19(03): 0304
DOI: 10.1055/s-0042-1752401

Innovative Drug Discovery and Development

Contributor(s):

Antonia F. Stepan (Roche)

,

Nadine Kuhl (MSD)

,

Danica A. Rankic (Pfizer)

Key words

somatostatin - paltusotine - SST2 agonist - acromegaly - neuroendocrine tumors - Suzuki coupling

Article published online:
13 February 2023

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany